Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic Patients

NCT01120925 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Liver Cirrhosis

Interventions

BIOLOGICAL: MNC
BIOLOGICAL: CD133
BIOLOGICAL: Control

Sponsor

Royan Institute

Collaborators

[object Object]